Form 8-K - Current report:
SEC Accession No. 0001437749-25-009859
Filing Date
2025-03-28
Accepted
2025-03-28 16:14:14
Documents
16
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20250327_8k.htm   iXBRL 8-K 28325
2 EXHIBIT 99.1 ex_795727.htm EX-99.1 85918
7 logosm.jpg GRAPHIC 12780
  Complete submission text file 0001437749-25-009859.txt   302948

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20250327.xsd EX-101.SCH 4061
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250327_def.xml EX-101.DEF 13826
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250327_lab.xml EX-101.LAB 18218
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250327_pre.xml EX-101.PRE 13858
18 EXTRACTED XBRL INSTANCE DOCUMENT govx20250327_8k_htm.xml XML 4894
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 25786409
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)